NCT05191771View on ClinicalTrials.gov

Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction

NAUnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2022

Conditions

Dry EyeMeibomian Gland Dysfunction

Interventions

DEVICE

Neovis Total Multi

1 drop in each eye, 4 times per day

DEVICE

Systane Balance

1 drop in each eye, 4 times per day

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Horus Pharma

INDUSTRY